This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991:206:173-83.

doi: 10.1016/0076-6879(91)06088-k.

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6

M H Heim, U A Meyer

PMID: 1686063
DOI: 10.1016/0076-6879(91)06088-k

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6

M H Heim et al. Methods Enzymol. 1991.

. 1991:206:173-83.

doi: 10.1016/0076-6879(91)06088-k.

Authors

M H Heim, U A Meyer

PMID: 1686063
DOI: 10.1016/0076-6879(91)06088-k

No abstract available

PubMed Disclaimer

Similar articles

Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.
Daly AK, Armstrong M, Monkman SC, Idle ME, Idle JR. Daly AK, et al. Pharmacogenetics. 1991 Oct;1(1):33-41. doi: 10.1097/00008571-199110000-00006. Pharmacogenetics. 1991. PMID: 1688241
NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus.
Mura C, Broyart JP, Jacqz E, Elion J, Krishnamoorthy R. Mura C, et al. Nucleic Acids Res. 1991 Mar 11;19(5):1162. doi: 10.1093/nar/19.5.1162. Nucleic Acids Res. 1991. PMID: 1673559 Free PMC article. No abstract available.
The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ. Kimura S, et al. Am J Hum Genet. 1989 Dec;45(6):889-904. Am J Hum Genet. 1989. PMID: 2574001 Free PMC article.
Molecular genetics of cytochrome P450 IID. Anomalies of drug metabolism.
Jacqz-Aigrain E, Panserat S, Sica L, Krishnamoorthy R. Jacqz-Aigrain E, et al. Clin Rev Allergy Immunol. 1995 Fall;13(3):211-21. doi: 10.1007/BF02771762. Clin Rev Allergy Immunol. 1995. PMID: 8535928 Review. No abstract available.
[Non small-cell bronchial cancer].
Coudert B. Coudert B. Bull Cancer. 1994;81 Suppl 1:21s-26s. Bull Cancer. 1994. PMID: 7727851 Review. French. No abstract available.

See all similar articles

Cited by

Polymerase chain reaction and its potential as a pharmacokinetic tool.
Heim MH. Heim MH. Clin Pharmacokinet. 1992 Nov;23(5):321-7. doi: 10.2165/00003088-199223050-00001. Clin Pharmacokinet. 1992. PMID: 1362142 Review. No abstract available.
Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
Gerstenberg G, Aoshima T, Fukasawa T, Yoshida K, Takahashi H, Higuchi H, Murata Y, Shimoyama R, Ohkubo T, Shimizu T, Otani K. Gerstenberg G, et al. Psychopharmacology (Berl). 2003 Jun;167(4):443-8. doi: 10.1007/s00213-003-1430-1. Epub 2003 Apr 8. Psychopharmacology (Berl). 2003. PMID: 12682708 Clinical Trial.
Polymorphic cytochromes P450 and drugs used in psychiatry.
Coutts RT, Urichuk LJ. Coutts RT, et al. Cell Mol Neurobiol. 1999 Jun;19(3):325-54. doi: 10.1023/a:1006945715127. Cell Mol Neurobiol. 1999. PMID: 10319191 Free PMC article. Review.
Assessment of liver metabolic function. Clinical implications.
Brockmöller J, Roots I. Brockmöller J, et al. Clin Pharmacokinet. 1994 Sep;27(3):216-48. doi: 10.2165/00003088-199427030-00005. Clin Pharmacokinet. 1994. PMID: 7988103 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science